# Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan

> **NCT04906070** · NA · COMPLETED · sponsor: **Hekabio** · enrollment: 14 (actual)

## Conditions studied

- Breast Cancer
- Head and Neck Cancer

## Interventions

- **DEVICE:** HB-001

## Key facts

- **NCT ID:** NCT04906070
- **Lead sponsor:** Hekabio
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-25
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-05-27
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04906070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04906070, "Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04906070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*